<DOC>
	<DOCNO>NCT00846391</DOCNO>
	<brief_summary>A study ass safety efficacy MK8245 monotherapy compare placebo .</brief_summary>
	<brief_title>A Study Assess Safety Efficacy MK8245 Patients With Type 2 Diabetes Mellitus Inadequate Glycemic Control ( MK8245-005 AM2 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Have Type 2 Diabetes Mellitus 18 65 year age History Type 1 Diabetes ketoacidosis Have treat lipid lower medication 4 week start study Have start weight loss program maintenance phase start weight loss medication within last 12 week Have surgery last 30 day History active liver disease History coronary heart disease congestive heart failure Have stroke transient ischemic neurological disorder past 6 month Are Human Immunodeficiency Virus ( HIV ) Positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>